• Sonuç bulunamadı

Pulmonary tuberculosis developed in sarcoidosis patients

N/A
N/A
Protected

Academic year: 2021

Share "Pulmonary tuberculosis developed in sarcoidosis patients"

Copied!
1
0
0

Yükleniyor.... (view fulltext now)

Tam metin

(1)

271

Pulmonary tuberculosis developed in sarcoidosis patients

doi • 10.5578/tt.67367

Tuberk Toraks 2018;66(3):271-272

Geliş Tarihi/Received: 02.09.2018 • Kabul Ediliş Tarihi/Accepted: 24.09.2018

Kunihiko MiyazaKi1 Hideyasu yaMada1 Tomohiro TaMura1 Toshihiro SHiozawa1 Hiroaki SaToH1

1 Division of respiratory Medicine, Mito Medical Center, University of Tsukuba-Mito Kyodo General Hospital, Japan

EdİTÖrE MEKTuP LETTER TO THE EDITOR

With great interest, we read the article by Ucsular et al.

on pulmonary tuberculosis in sarcoidosis patients (second issue 2018, Tuberk Toraks. 2018) (1). The results of this article were interesting and agreeable contents. We would like to share our experience (2,3).

Based on the experience, we would like to ask the author two questions.

We also experienced a similar case before (2,3). Our patient was a 55-year-old male and treated with corti- costeroid he had rapidly progressive sarcoidosis three years before. After completion of corticosteroid the- rapy, cavitary lesion developed, which was diagnosed as pulmonary tuberculosis. As indicated by the aut- hors, an immunosuppressive state during corticostero- id therapy are high risk patients of tuberculosis. We agree with this, but we would like ask the authors whether they evaluated sarcoidosis it self as a risk of developing tuberculosis. In two patients described by the authors, there was no cavitary lesion in both lungs (1). This was apparently different image finding from our patient. We would like to hearing from the authors were there characteristic image findings in sarcoidosis patients who develop pulmonary tuberculosis.

rEFErENCES

1. Ücsular F, Karadeniz G, Polat G, Yalniz E. Pulmonary tuberculasis in sarcoidosis patients: two cases. Tuberk Toraks 2018;66:182-4.

2. Suyama T, Satoh H, Inoue T, Noguchi Y, Ohtsuka M, Yosizawa Y, et al. A case of sarcoidosis presenting with high fever and acute respiratory failure.

Kekkaku.1990;65:811-9 (in Japanese).

3. Satoh H, Suyama T, Ishida H, Noguchi Y, Yagyu H, Ishikawa H, et al. A case of sarcoidosis who developed pulmonary tuberculosis after completion of steroid administration. Jpn J Chest Dis 1992;51:121-4 (in Japanese).

Dr. Hiroaki SaTOH

Division of Respiratory Medicine, Mito Medical Center, University of Tsukuba, Mito-Japan

e-mail: hirosato@md.tsukuba.ac.jp

yazışma adresi (address for Correspondence)

Tuberk Toraks 2018;66(3):271-272

Referanslar

Benzer Belgeler

Antiretroviral tedavi ve antitüberküloz tedavi alınması nedeniyle ilaç etki- leşimi riskinin artması, çok ilaç kullanımına bağlı ilaç uyumunda azalma, her iki hastalığın

This study was aimed to determine the resistance pattern of Mycobacterium tuberculosis among new cases, cured, failure, relapse, defaulted, treatment completed, treatment not

In our two pati- ents, there was no cavitary lesion, but the patients who were referred to us with suspicion of sarcoidosis progressi- on due to the development of new

Higher rate for secondary tuberculosis was noted in smear positive (3.1%) than in smear negative (1.0%) contacts along with the efficacy of prophylaxis both in childhood and

In our population, the most commonly identified major occupational group was “craft and related trades wor- kers” (32.0%) of which “textile, garment and related trades

In the present study, there was no statisti- cally significant difference between sputum smear conversion rate and age groups, neither in DOT managed nor non-DOT managed pati-

Figure 4: Follow-up chest X-ray after antituberculosis treatment revealed radiological improvement of parenchymal nodules but no change in lymph nodes or

Sonuç olarak, Osmaniye ilinin yıllara göre TB vaka analizi yapıldığında gerek nüfusu gerekse olgu hızı itibariyle paralellik göstermesinden dolayı Türkiye’nin